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Not All Body Fat Weighs Equally in the Acceleration
of Coronary Artery Disease*
Daniel S. Berman, MD, Victor Y. Cheng, MD, Damini Dey, PHD
Los Angeles, CaliforniaAs a component of the metabolic syndrome, abdom-
inal obesity has been more closely associated with both
cardiovascular events (1–3) and acute coronary syn-
drome (4) than standard measures of adiposity such as
body mass index (5). Abdominal visceral adipose
tissue (VAT) is a specific measurement of abdominal
obesity. Abdominal VAT has been linked to insulin
resistance and hepatic production of inflammatory
factors, potentially through direct hepatic drainage of
its metabolites (6).
See page 908
Computed tomography (CT) is recognized as a
highly effective, accurate, and reproducible tech-
nique for measuring VAT by detecting the charac-
teristic low Hounsfield units of fat (7,8). On non-
contrast CT, abdominal VAT has been linked to
development of myocardial infarction (9). In this
issue of iJACC, Ohashi et al. (10) report further
evidence of the relationship between abdominal
VAT and the pathogenesis of coronary atheroscle-
rosis and acute coronary syndrome. In 427 patients
with known or suspected coronary artery disease
who underwent coronary computed tomography
angiography (CTA), the authors report the rela-
tionships between axially imaged abdominal VAT
area and noncalcified coronary plaques on coronary
CTA. Increased abdominal VAT area was signifi-
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of noncalcified plaques, whereas other body com-
position measures (subcutaneous adipose tissue,
body mass index, waist circumference) were not.
The most striking new observation was that in-
creased VAT area was also independently associ-
ated with the presence of 3 plaque characteristics
previously shown to be related to an increased risk
of acute plaque rupture: positive remodeling, low-
attenuation plaque, and adjacent spotty calcification
(11,12). These findings represent another step to-
ward gaining insight into the mechanism by which
VAT is associated with acute coronary syndrome
and support the hypothesis that VAT contributes to
the instability of coronary arterial plaques.
Noticeably absent from this work, however, are
data regarding pericardial fat (visceral fat around
the heart) and pericoronary fat (fat immediately
adjacent to the coronary artery). While pericardial
fat correlates strongly with abdominal VAT
(13,14), paracrine effects of the pericardial and
pericoronary fat beds may be more potent determi-
nants of coronary plaque development and progres-
sion than VAT.
Mazurek et al. (15) studied adipose tissue adja-
cent to the right coronary artery removed during
surgical bypass surgery and found it to contain
significantly higher levels of inflammatory markers
than subcutaneous fat. This finding has been sub-
stantiated in subsequent publications (16,17) and
suggests that proximity of pericardial fat to the
coronary arteries amplifies its paracrine role in
promoting inflammation, resulting in a local toxic
effect on the coronary arteries. Evidence that the
pericardial fat may directly affect plaque develop-
ment has also been provided by a 3-dimensional
ultrasound study that demonstrated eccentric ath-
erosclerotic plaques develop with a spatial orienta-
tion suggestive of a relationship with pericardial fat
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91918). Further, autopsy evidence has shown that
oronary arteries with large necrotic cores have
ore macrophages in the periadventitial fat than in
essels without a lipid core (19).
Pericardial fat can be quantified by cardiac CT,
nd multiple publications have implicated its role in
he pathophysiology of coronary atherosclerosis. In
report from the Multi-Ethnic Study of Athero-
clerosis (MESA) study, Ding et al. (20) showed
hat pericardial fat on noncontrast CT was associ-
ted with increased coronary calcium burden. Ma-
abadi et al. (21) recently described a strong asso-
iation between pericoronary fat volume on
oncontrast CT and the presence of calcified plaque
n the underlying coronary segment. Alexopoulos et
l. (22) observed on coronary CTA a significant
ncrease in adipose tissue volume within the peri-
ardial sac (epicardial adipose tissue) with increas-
ng severity of coronary luminal stenosis. In this last
tudy, epicardial adipose tissue volume was larger in
atients with mixed or noncalcified plaques,
rompting the authors to suggest that epicardial
dipose tissue may be associated with the “most
angerous” plaques.
Pericardial fat has also been linked to the devel-
pment of major adverse cardiac events (MACE).
ahabadi et al. (23) studied the associations be-
ween pericardial fat and visceral VAT on noncon-
rast CT with subsequent cardiovascular events in
symptomatic participants of the Framingham
eart Study. In this study, after adjustment for
tandard clinical measures including body mass
ndex and waist circumference, pericardial fat was
ore strongly associated with subsequent events
han abdominal VAT. Interestingly, pericardial fat
as predominantly associated with MACE,
hereas only abdominal VAT was associated withyear follow up of participants in the
population study of women in Goth- Tylen U, Sjöströmmpact atherogenesis differently, with abdominal
AT having a more systemic effect and pericardial
at a more local effect on the coronary arteries (24).
n a case-control study in which pericardial fat was
easured from noncontrast coronary calcium CT
y a semiautomated method, we found that asymp-
omatic patients who experienced MACE exhibited
greater pericardial fat volume when compared
ith event-free control subjects (24). The addition
f pericardial fat volume to conventional clinical
isk stratification and coronary artery calcium score
mproved the prediction of MACE in this popula-
ion. In a subsequent case-control study of patients
ho underwent myocardial perfusion imaging
ithin 6 months of noncontrast CT, we have
hown that, after adjusting for the coronary calcium
core, pericardial fat volume was strongly associated
ith ischemia (25).
The findings of Ohashi et al. (10) provide im-
ortant information regarding the relationship be-
ween abdominal VAT and the genesis of acute
oronary syndromes. However, existing literature
ontinues to speak strongly for an even more
mportant role for the fat around the heart. As
vidence supporting the relationship between in-
reased pericardial fat, coronary atherosclerosis, and
dverse coronary events continues to mount, measure-
ent of pericardial fat from cardiac CT appears
rimed to ultimately become a routine complement to
he information gained from plaque evaluation. This
ssessment could generate CT information regarding
he activity of the atherosclerotic process, potentially
dding meaningfully to clinical risk assessment.
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